Lori Valigra

US dominance in innovation can no longer be assumed, believe the CEOs of some of its leading technology companies. Competitiveness is set to be a key issue in the 2008 Presidential election

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

Leading researchers seeking to stave off modern plagues are making progress in understanding the mechanisms of diseases such as influenza and anthrax.

The United States has long set the global standard as the model for innovation and entrepreneurship. But a new report by the venerable Kauffman Foundation says the cracks are showing.

The value of R&D coming out of US universities is increasing. And the question of exactly how Europe measures up in comparison may soon be answered.

Matching consumer demand with R&D may seem like an obvious starting point for innovation. But it has proven a transient goal for many countries and companies.

The innovation winners will have to use a more disciplined – and science-based – approach to garnering new ideas, says a leading consultant.

Is early-stage investing dead? Not by a long shot in the US. The US market for early-stage investing is on the rise - good news whether you're seeking or investing money.

Corporations may be their own worst enemy when it comes to new ideas and innovations, which is good news for external partners, says an IBM executive.

A pay-per-vote Web site offers a new way to fund science, one dollar at a time.